- Home
- Available Courses
Most Recent Courses
CVD and Type 2 Diabetes: Navigating Therapeutic Boundaries in GLP-1 RA Use
- 2 EBAC
Published:
Learning objectives
- Describe the burden of ASCVD in type 2 diabetes
- Assign risk of future CV events to individuals with type 2 diabetes
- Identify appropriate patients for GLP-1 RA therapy based on clinical trial outcome data to reduce ASCVD risk
- Recall trial data of anti-diabetes medications that reduce ASCVD risk
- Recall the pleiotropic effects of GLP-1 RAs and how these may impact CV outcomes
- Describe how early adoption of anti-diabetes therapies with proven CV benefit can positively influence QOL
- Adopt anti-diabetic therapies with proven ASCVD benefit
HCM in Review: Highlights of 2022
- 0.25 AMA PRA Credit
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments
- Summarise results from ongoing trials with experimental treatments
Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation
- 1.00 EBAC
Published:
Learning objectives
- Recall the long-term outcomes of TEER from real-world and RCT data
- Apply the results of real-world data to both simple and complex patients
- Describe how TEER is being used to benefit a range of patients with MR
HCM in Review: Assessing SCD Risk in HCM & Managing HCM With High Risk SCD
- 0.50 AMA PRA Credit
Published:
Learning objectives
- Recall risk factors associated with sudden cardiac death (SCD)
- Recall best practice approaches to prevent SCD according to guidelines and expert insight
- Stratify patients likely to benefit from invasive procedures versus pharmacological treatment
Changing Paradigms in Therapy to Unmet Needs
- 1 EBAC
Published:
Learning objectives
- Recall the utility of EF in heart failure treatment, patient selection and treatment response
- Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy
- Incorporate quality of life measures for assessing therapeutic efficacy in HF
- Recall outcomes from heart failure trials from recent congress and publications and their impact on practice
Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
- 1 EBAC
Published:
Learning objectives
- Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
- Summarise clinical evidence for TAVI in low surgical risk patients
- Recall different guideline recommendations for SAVR and TAVI approaches
- Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
Renal Denervation In The Real World: Practical Guidance For New Users
- 1 EBAC
Published:
Learning objectives
- Assess the current global burden of resistant hypertension
- Carry out appropriate assessments to identify resistant hypertension
- Identify patients most likely to benefit from RDN
- Recall the practical considerations for adopting RDN into routine practice
- Recall the latest data on RDN from recent clinical trials
SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure
- 1 EBAC
Published:
Learning objectives
- Recall the results of key trials in HFmrEF in different patients' sub-groups
- Describe how SGLT-2 inhibitors can be used across the range of LVEF
- Apply emerging diagnostic approaches for HFpEF and HFmrEF
- Implement best-practice strategies across the range of LVEF
Hypertrophic Cardiomyopathy in Review: ESC–HFA 2022 & How to Differentiate HCM From Its Phenocopies
- 0.50 AMA PRA Credit
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments and summarise results from ongoing trials with experimental treatments
- Differentiate the signs and symptoms of HCM from other conditions that frequently mask, or mimic the disease and in the presence of comorbidities